iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.630
-0.080 (-4.68%)
At close: Apr 28, 2026, 4:00 PM EDT
1.658
+0.028 (1.70%)
After-hours: Apr 28, 2026, 7:23 PM EDT
iBio, Inc. Employees
iBio, Inc. had 20 employees as of June 30, 2025. The number of employees increased by 4 or 25.00% compared to the previous year.
Employees
20
Change (1Y)
4
Growth (1Y)
25.00%
Revenue / Employee
$15,000
Profits / Employee
-$1,236,850
Market Cap
58.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 119 |
| MindWalk Holdings | 102 |
| OnKure Therapeutics | 45 |
| BeyondSpring | 44 |
| Cue Biopharma | 29 |
| ImageneBio | 15 |
| Cingulate | 14 |
| Instil Bio | 14 |
IBIO News
- 20 days ago - iBio, Inc. Transcript: Status update - Transcripts
- 20 days ago - iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia - GlobeNewsWire
- 6 weeks ago - iBio, Inc. Transcript: Study update - Transcripts
- 6 weeks ago - iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - GlobeNewsWire
- 7 weeks ago - iBio, Inc. Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss - GlobeNewsWire
- 2 months ago - iBio, Inc. Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - iBio to Participate in Upcoming Investor Conferences - GlobeNewsWire